CD93
Complement component C1q receptor | ||
---|---|---|
other names |
C1q / MBL / SPA receptor, C1qR, C1qR (p), C1qRp |
|
Properties of human protein | ||
Mass / length primary structure | 652 amino acids , 68,560 Da | |
Identifier | ||
External IDs | ||
Orthologue (human) | ||
Entrez | 22918 | |
Ensemble | ENSG00000125810 | |
UniProt | Q9NPY3 | |
Refseq (mRNA) | NM_012072.3 | |
Refseq (protein) | NP_036204.2 | |
PubMed search |
22918
|
CD93 (synonym Complement component C1q receptor ) is a surface protein from the group of complement receptors .
properties
CD93 is mainly produced by endothelial cells , platelets and myeloid cells (such as monocytes and neutrophils ), but not by lymphoid cells. CD93 is the receptor for C1q , MBL 2 and surfactant protein A . CD93 is believed to be involved in cell adhesion . After binding soluble collagens , it increases the phagocytosis of monocytes and macrophages . CD93 is glycosylated and phosphorylated .
Web links
Individual evidence
- ^ MC Greenlee-Wacker, MD Galvan, SS Bohlson: CD93: recent advances and implications in disease. In: Current drug targets. Volume 13, Number 3, March 2012, pp. 411-420, PMID 22206251 .